Search

Author/Creator Han, C.

41. FRI0178 Five-year safety and efficacy of golimumab in methotrexate-naïve patients with rheumatoid arthritis: final study results of the phase 3, randomized, placebo-controlled go-before trial. (23rd January 2014)

Authors:
Emery, P.; Fleischmann, R. M.; Strusberg, I.; Durez, P.; Nash, P.; Amante, E.; Churchill, M.; Park, W.; Pons-Estel, B.; Han, C.; Gathany, T.; Zhou, Y.; Xu, S.; Hsia, E. C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A432
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

42. FRI0211 Safety and efficacy of subcutaneous golimumab in chinese patients with active rheumatoid arthritis despite mtx therapy: results from a randomized, placebo-controlled, phase 3 trial. (23rd January 2014)

Authors:
Li, Z.; Zhang, F.; Kay, J.; Fei, K.; Han, C.; Zhuang, Y.; Wu, Z.; Hsia, E. C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A444
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

43. FRI0266 Health-Related Quality of Life of Patients with Rheumatoid Arthritis Achieving DAS28 Remission, Improvement in Physical Function and NO Radiographic Progression after Treatment with Intravenous Golimumab. (10th June 2014)

Authors:
Westhovens, R.; Weinblatt, M.E.; Han, C.; Kim, L.; Mack, M.; Lu, J.; Baker, D.; Mendelsohn, A.; Bingham, C.O.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
479
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗